These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22191450)

  • 1. Salmonella enterica as a vaccine carrier.
    Hegazy WA; Hensel M
    Future Microbiol; 2012 Jan; 7(1):111-27. PubMed ID: 22191450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of Salmonella recombinant vaccines.
    Cheminay C; Hensel M
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.
    Hegazy WA; Xu X; Metelitsa L; Hensel M
    Infect Immun; 2012 Mar; 80(3):1193-202. PubMed ID: 22252866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].
    Hernández-Luna MA; Luria-Pérez R; Huerta-Yépez S
    Rev Invest Clin; 2013; 65(1):65-73. PubMed ID: 23745445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
    Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.
    Hegde NR; Kaveri SV; Bayry J
    Drug Discov Today; 2011 Dec; 16(23-24):1061-8. PubMed ID: 21782969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of Salmonella-based vaccine strategies for protection against Salmonellosis in humans.
    Sears KT; Galen JE; Tennant SM
    J Appl Microbiol; 2021 Dec; 131(6):2640-2658. PubMed ID: 33665941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.
    Kirkpatrick BD; McKenzie R; O'Neill JP; Larsson CJ; Bourgeois AL; Shimko J; Bentley M; Makin J; Chatfield S; Hindle Z; Fidler C; Robinson BE; Ventrone CH; Bansal N; Carpenter CM; Kutzko D; Hamlet S; LaPointe C; Taylor DN
    Vaccine; 2006 Jan; 24(2):116-23. PubMed ID: 16140433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen.
    Wang L; Curd H; Reeves PR
    Microb Pathog; 1999 Jul; 27(1):55-9. PubMed ID: 10371709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.
    Nagy G; Danino V; Dobrindt U; Pallen M; Chaudhuri R; Emödy L; Hinton JC; Hacker J
    Infect Immun; 2006 Oct; 74(10):5914-25. PubMed ID: 16988271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of auxotrophies on the release of macromolecules by Salmonella enterica vaccine strains.
    Loessner H; Endmann A; Rohde M; Curtiss R; Weiss S
    FEMS Microbiol Lett; 2006 Dec; 265(1):81-8. PubMed ID: 17034415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.